
BCVS - Basic Cardiovascular Sciences - American Heart Association
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to BCVS - Basic Cardiovascular Sciences - American Heart Association — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.
About this event
BCVS (Basic Cardiovascular Sciences) Scientific Sessions — American Heart Association (AHA)
BCVS Scientific Sessions is one of the American Heart Association’s key bench-science gatherings focused on foundational cardiovascular research, translational discovery, and next-step scientific communication across the cardiovascular ecosystem. We use this event for deep buyer and attendee research because it attracts a high-density audience of cardiovascular scientists, academic leaders, research administrators, industry scientific teams, and translational/program decision-makers.
Official Event Basics (Verified From the Provided Official Page)
- Event name: BCVS (Basic Cardiovascular Sciences) Scientific Sessions
- Organizer: American Heart Association (AHA)
- Confirmed session dates (as stated): July 23–26, 2025
- Venue city: Baltimore, Maryland
- Venue country: United States
- Additional page reference (as stated): “#BCVS26, July 13–16 in Boston, Massachusetts” (Year 2026 referenced by hashtag)
1️⃣ Who Attends (Buyers / Attendees)
This event is not a typical consumer or retail conference. BCVS is science-led and audience-composition tends to be heavy in “research ecosystem” roles. For attendee-list and buyer-list research, we treat “buyers” as the people most able to evaluate, purchase, sponsor, collaborate on, or influence scientific services and cardiovascular-related solutions.
Main attendee/buyer groups we see fit for this type of event:
- Academic cardiovascular researchers and lab leaders (faculty, principal investigators, department-level research leaders)
- Research administrators and translational program leaders (university research offices, clinical research leadership, discovery-to-development program staff)
- Corporate R&D and scientific leadership (cardiovascular therapeutics, drug discovery, device research, preclinical teams)
- Regulatory/scientific policy-adjacent stakeholders (scientific strategy and evidence-generation leadership)
- Healthcare innovation and research partnerships stakeholders (collaboration management, scientific alliances, grant/consortium participation)
- Communications and medical education stakeholders (when research content translates into professional education)
Best “buyer” framing for our outreach: We position BCVS as a targeted environment to reach decision-makers who influence research investment, partnerships, evidence generation, scientific communications, and cardiovascular discovery workflows.
2️⃣ Where the Show Is Happening + Attendee Geographic Origin
2025 location (verified): Baltimore, Maryland, United States.
2026 reference (from the same provided page text): Boston, Massachusetts, United States.
Attendee geographic origin (research-based expectation for AHA science meetings):
- Strong United States concentration: AHA is a U.S.-centered organization with broad national reach into research institutions, hospitals, and corporate labs.
- Major international representation: Cardiovascular bench science is globally relevant, so we typically expect international attendees via collaborations, visiting scientists, and global industry research sites.
- Research-hub clustering: Expect elevated density from states with strong academic/biotech ecosystems and research hospitals.
Best geographic targeting approach we recommend: We build buyer targeting based on where the decision-makers work (U.S. research institutions and companies with cardiovascular programs), and we optionally expand to global research-affiliated organizations depending on your target product’s footprint.
3️⃣ Audience Reach (Local / National / Global)
BCVS scientific content is designed for a national research audience with international scientific relevance. For buyer research, we classify expected reach as: National (primary) + Global (secondary).
- Local reach: Baltimore/Boston regional attendance is meaningful, but core value typically comes from nationwide participation.
- National reach: Very high relevance due to AHA’s reach across U.S. academic medicine, research hospitals, and corporate cardiovascular programs.
- Global reach: Scientific topics and reputation help attract international researchers and industry scientific stakeholders.
4️⃣ Sample Buyer Company Names (Buyers Only) + Websites
Below are buyer-style sample targets—companies whose cardiovascular research, translational pipeline, or scientific strategy teams commonly align with bench-science conferences like BCVS. We tailor the “Best Title to Target” to buyer influence (research leadership, evidence generation, translational strategy, scientific operations).
Note: Final buyer suitability depends on your product category, target customer type, and whether we are focusing on scientific partnerships, R&D programs, clinical research enablement, or scientific communications/education. We can tighten this list once we review your product fit and website.
| Priority | Company | Website | Best Title to Target | Why This is a Good Buyer Fit |
|---|---|---|---|---|
| 1 | Roche | roche.com | Head of Cardiovascular Translational Research / Therapeutic Area Leader (Cardiovascular) | Strong cardiovascular science footprint; translational research leadership aligns with bench-to-pipeline conversations. |
| 2 | Novartis | novartis.com | Vice President, Cardiovascular R&D / Translational Medicine Lead | Cardiovascular therapeutic development teams often attend to track scientific progress and partnership opportunities. |
| 3 | Pfizer | pfizer.com | Director, Cardiovascular Discovery / Head of Preclinical Strategy | Preclinical and discovery leaders benefit from bench-science updates and evidence direction. |
| 4 | Merck & Co., Inc. | merck.com | Senior Director, Cardiovascular Research / Evidence Generation Strategy Lead | Evidence-generation and cardiovascular research strategy teams align well with basic science sessions. |
| 5 | Johnson & Johnson (Janssen) | janssen.com | Therapeutic Area Scientific Lead (Cardiovascular) / Translational Medicine Director | Therapeutic-area scientific leadership matches BCVS’s translational discovery ecosystem. |
| 6 | Gilead Sciences | gilead.com | Director, Cardiovascular/R&D Partnerships / Scientific Program Manager | Partnership and program leadership can connect research collaborations to pipeline priorities. |
| 7 | Amgen | amgen.com | Associate Director/Director, Cardiovascular Research / Translational Science Lead | Scientific leadership teams use meetings to guide translational strategy and scientific collaborations. |
| 8 | Sanofi | sanofi.com | Head of Cardiovascular Innovation / Translational Medicine Lead | Cardiovascular innovation leadership is an ideal fit for bench-science updates and evidence alignment. |
| 9 | Bayer | bayer.com | Director, Cardiovascular Scientific Strategy / Clinical-Translational Evidence Lead | Scientific strategy roles benefit from bench-to-translational scientific direction. |
| 10 | AbbVie | abbvie.com | Director, Cardiovascular R&D / Translational Science Program Lead | Translational R&D program leaders align with the BCVS research focus areas. |
| 11 | Pfizer Medical Affairs / Scientific Communications (Pfizer corporate ecosystem) | pfizer.com | Director, Medical Education & Scientific Communications (Cardiovascular) | When BCVS content informs professional education and clinical evidence planning, these roles become highly relevant. |
| 12 | Thermo Fisher Scientific | thermofisher.com | Director, Life Sciences Research Solutions (Cardiovascular/Cell Biology) / Scientific Applications Lead | Scientific applications and research solutions map closely to bench-science workflows. |
| 13 | Danaher (e.g., Applied Biosystems / Research brands) | danaher.com | Product Marketing Manager / Scientific Applications Manager (Cardiovascular Research Use Cases) | Research tools and workflows can be positioned around cardiovascular bench research needs. |
| 14 | GE HealthCare | gehealthcare.com | Director, Preclinical/Imaging Research Solutions / Clinical Research Imaging Strategy | Where imaging and research instrumentation intersects with cardiovascular discovery, this is a strong fit. |
| 15 | Medtronic | medtronic.com | Director, Translational Research / Clinical Science Strategy (Cardiovascular) | For device and translational evidence strategy, BCVS’s foundational science is highly relevant. |
| 16 | Boston Scientific | bostonscientific.com | Director, Research & Development Science Strategy / Translational Research Lead | Scientific strategy teams align with discovery-to-evidence narratives. |
| 17 | Cardiovascular Academic Consortium (Targeting organizations varies) | aha.org | Research Office Director / Cardiovascular Research Center Director | Academic centers connected to cardiovascular research infrastructure are often key “buyers” for research enablement services. |
| 18 | IQVIA (research and evidence enablement ecosystem) | iqvia.com | Director, Evidence & Real-World Scientific Strategy / Life Sciences Partnerships Lead | Evidence teams often engage where bench insights translate to outcomes research and evidence planning. |
Top 5 sample buyer targets to start outreach (based on common cardiovascular engagement): Roche, Novartis, Pfizer, Thermo Fisher Scientific, Medtronic. These map well to cardiovascular discovery, translational strategy, and research tooling ecosystems.
5️⃣ Job Profiles, Industries & Event Type
Best job profiles to target (titles we would prioritize in a buyer list):
- Therapeutic Area Leader (Cardiovascular)
- Director/VP, Cardiovascular R&D
- Head of Translational Medicine (Cardiovascular)
- Preclinical Discovery Lead
- Scientific Strategy Lead / Evidence Generation Strategy Manager
- Scientific Program Manager (Cardiovascular)
- Clinical Science Strategy Lead (Cardiovascular) [where applicable]
- Director, Medical Education & Scientific Communications (Cardiovascular)
- Director, Scientific Applications / Research Solutions (life science tools)
- Research Center Director / Cardiovascular Research Center Leadership (academia)
Industries to apply (from the provided Apollo-style industry list equivalents) we recommend for filtering:
- Pharmaceuticals
- Medical Devices
- Biotechnology
- Health, Wellness & Fitness
- Hospital & Health Care
- Research
- Professional Training & Coaching (only if your product is education/enablement related)
- Information Technology & Services (only if your product is scientific data platforms, research informatics, or lab software)
Event type (what this conference effectively is): AHA bench-science / translational discovery scientific sessions for cardiovascular fundamentals, research communications, and scientific networking across academia and industry.
6️⃣ Estimated Attendance (Expected Total Footfall)
The provided official text does not include an attendance estimate. For accuracy, we leave this blank until we can source it from an official AHA page section (registration/FAQ/press kit) or a reputable secondary report.
Estimated attendance (unavailable in provided source):
7️⃣ Key Focus Areas & Buyer Engagement
BCVS content centers on Basic Cardiovascular Sciences and “latest research & advancements” as stated on the provided page. That creates multiple engagement angles for buyer outreach, depending on your client’s product category.
Key focus areas (buyer-relevant themes):
- Foundational cardiovascular biology (bench science)
- Translational research pathways (how discovery moves toward application)
- Mechanisms behind cardiovascular disease and cardiometabolic/vascular relevance
- Research evidence standards and scientific collaboration networks
- Scientific communication and professional dissemination of discoveries
Buyer engagement approach that works well for this event:
- Frame outreach around “accelerating discovery-to-translation” rather than generic event attendance.
- Map your product’s value to bench workflows (data generation, experimental design support, research enablement, scientific program alignment, or evidence planning).
- Use cardiovascular-relevant keywords in targeting (cardiovascular translational medicine, preclinical discovery, scientific strategy, evidence generation, cardiovascular research center leadership).
8️⃣ Client Product Fit Note (We need your client website to finalize the best buyers)
We can absolutely refine this into the best buyer shortlist based on your exact product, but we need your client details first. Please share your client website so we can review it and map buyer titles and industries that match your solution.
What we will do after you share the website:
- We will identify which buyer segment is most aligned (pharma/biotech R&D, medical devices translational science, research tools, evidence/eLearning/education, informatics, or hospital research leadership).
- We will prioritize “Best Title to Target” to match the decision-maker logic for your offer.
- We will produce a tighter list of target companies and roles specifically connected to cardiovascular bench-to-translation needs.
- We will align industries using the industry list categories you provided (e.g., Pharmaceuticals, Medical Devices, Biotechnology, Research, Hospital & Health Care, etc.).
Please send:
- Your client website URL
- What the product does in one sentence (and who the end customer is)
- Geography focus (US only, or global)
- Whether the priority is scientific R&D buyers, translational program buyers, or research enablement buyers
9️⃣ Final Recommendation (Is BCVS a good fit for attendee/event research and buyer targeting?)
Yes—BCVS is a strong fit for deep buyer research if your client’s offering supports any part of the cardiovascular research ecosystem: bench science enablement, translational medicine strategy, evidence generation, research infrastructure, scientific communications, or research tools/platforms.
Overall buyer-quality rationale:
- High relevance: The event is explicitly oriented around Basic Cardiovascular Sciences and “latest research & advancements.”
- Decision-maker adjacency: Many attendees are not only presenters; they sit in roles that shape research directions and scientific programs.
- Targetable segments: Pharma/biotech, medical devices, research tools, and academic research leadership can all be targeted depending on your product fit.
Action we recommend next: Share your client website, and we will deliver the most relevant buyer shortlist (company + website + best job titles) mapped to your exact requirements and the cardiovascular bench-to-translation context of BCVS.
Data sheet
| Event Name | BCVS - Basic Cardiovascular Sciences - American Heart Association |
| Event Date | July 13–16, 2026 |
| Event Status | Upcoming; current official page excerpt provided reflects a prior 2025 edition |
| Venue | Sheraton Boston |
| City | Boston |
| State / Region | MA |
| Country | United States |
| Organizer | American Heart Association (AHA) |
| Official Event Website | professional.heart.org/en/meetings/basic-cardiovascular-sciences |
| Event Type | Scientific conference / research meeting |
| Primary Category | Science & Research |
| Secondary Applicable Categories | Medical & Pharma; Wellness, Health & Fitness |
| Audience Reach | National with select international research participation |
| Estimated Attendance / Expected Footfall | Attendance figure not publicly confirmed by the organizer. |
| Attendance Data Reliability | Low to Medium; official page excerpt confirms the event brand and scientific focus, but no current-year attendance count was provided. |
| Main Purpose of Event | To present cutting-edge basic cardiovascular science, foster collaboration, and connect researchers, clinicians, trainees, sponsors, and academic/industry stakeholders. |
BCVS is the American Heart Association’s flagship meeting focused on basic cardiovascular sciences, with an emphasis on bench-to-bedside discovery, mechanistic research, and emerging technologies that advance cardiovascular medicine. The official AHA page describes it as the “most important bench science conference of the year,” highlighting its role as a high-value forum for scientific exchange and research visibility.
The event is especially relevant for academic investigators, translational researchers, trainees, biotech and pharma stakeholders, and organizations seeking scientific partnerships, clinical insights, and early awareness of cardiovascular innovation. For B2B outreach, the meeting is most useful for identifying research leaders, KOLs, technology evaluators, grant-funded labs, and life sciences organizations aligned with cardiovascular R&D.
| Buyer / Attendee Segment | Typical Organizations | Buying Role or Influence | Relevance to Exhibitors / Suppliers |
|---|---|---|---|
| Academic researchers / principal investigators | Universities, medical schools, research institutes | Influence on lab purchases, grants, and collaborations | High relevance for instruments, reagents, software, imaging, and CRO services |
| Translational science leaders | Academic medical centers, research hospitals, institutes | Evaluate technologies moving from lab to clinic | Strong for diagnostics, biomarkers, digital health, and trial support vendors |
| Core facility / lab operations leaders | Core labs, research centers, shared resource facilities | Specify and purchase lab infrastructure | Key for instrumentation, service contracts, consumables, and workflow tools |
| Biotech / pharma R&D leaders | Biotechnology firms, pharmaceutical companies | R&D budget owners and scientific evaluators | High value for preclinical models, assay platforms, and discovery services |
| Clinical trial / translational program managers | Hospitals, CROs, academic trial offices | Coordinate study execution and vendor selection | Relevant for recruitment, data, regulatory, and trial operations suppliers |
| Graduate students, postdocs, fellows | Universities, hospitals, research labs | Influence future tool preferences and lab workflows | Useful for brand building, education, and pipeline development |
| Scientific vendors and solution providers | Life sciences tools, reagents, lab technology companies | Commercial exhibitors and relationship builders | Important for sponsorship, booth traffic, and technical lead generation |
| Association leaders / scientific society staff | AHA councils, nonprofit science organizations | Program, education, and partnership decisions | Relevant for education platforms, event services, and publishing solutions |
| Geographic Area | Likely Attendee Origin | Buyer Concentration | Notes |
|---|---|---|---|
| Host city: Boston | Local universities, hospitals, biotech, and research staff | High | Boston is a major life sciences and academic medicine hub. |
| Host state / region: Massachusetts / Northeast | Regional research institutions, medical centers, biotech firms | High | Strong regional drive-in attendance expected. |
| Nearby business hubs | Cambridge, Providence, New York, New Haven, Philadelphia | Medium to High | Close proximity to academic and biotech ecosystems. |
| National reach | U.S. researchers, clinicians, trainees, and vendors | High | AHA meetings typically draw broad national participation. |
| International reach | Global cardiovascular researchers and industry participants | Medium | Likely international scientific interest, but no current-year attendee list confirmed. |
| Reach Level | Assessment | Explanation |
|---|---|---|
| National | Primary classification | AHA scientific meetings typically attract attendees from across the United States, especially academic, clinical, and life sciences organizations. |
| Global | Secondary reach description | International researchers and vendors may participate, but no current-year official attendance list was supplied. |
| Buyer Company / Organization | Buyer Type | Why It Is Relevant | Website | Best Job Titles to Target | Evidence Level |
|---|---|---|---|---|---|
| American Heart Association | Association / organizer | Organizer and scientific community leader for cardiovascular education and research. | heart.org | Conference Director, Scientific Program Director, Partnerships Director | Confirmed Speaker Organization |
| Mass General Brigham | Academic medical system | Major cardiovascular research and clinical care network in Boston. | massgeneralbrigham.org | Research Director, Cardiology Chair, Procurement Manager | Strong Market Fit, Attendance Not Confirmed |
| Brigham and Women’s Hospital | Hospital / research institution | Cardiovascular research, clinical trials, and academic collaborations. | brighamandwomens.org | VP Research, Lab Director, Clinical Trial Manager | Strong Market Fit, Attendance Not Confirmed |
| Massachusetts General Hospital | Hospital / academic medical center | High cardiovascular research and physician-scientist concentration. | massgeneral.org | Cardiology Director, Research Administrator, Purchasing Director | Strong Market Fit, Attendance Not Confirmed |
| Harvard Medical School | Academic institution | Major source of cardiovascular research faculty and trainees. | hms.harvard.edu | PI, Department Chair, Grants Manager | Strong Market Fit, Attendance Not Confirmed |
| Boston Children’s Hospital | Pediatric hospital / research center | Relevant for pediatric cardiovascular science and translational research. | childrenshospital.org | Research Director, Procurement Lead, Clinical Operations Director | Strong Market Fit, Attendance Not Confirmed |
| Boston University Chobanian & Avedisian School of Medicine | Academic medical school | Cardiovascular faculty, trainees, and research programs. | bu.edu/medicine | Faculty PI, Lab Manager, Department Administrator | Strong Market Fit, Attendance Not Confirmed |
| Novartis | Pharmaceutical company | Cardiovascular R&D, clinical development, and partnership scouting. | novartis.com | VP R&D, Translational Medicine Head, External Innovation Lead | Strong Market Fit, Attendance Not Confirmed |
| AstraZeneca | Pharmaceutical company | Cardiovascular and renal research interest; potential collaboration target. | astrazeneca.com | Medical Affairs Director, R&D Director, Alliance Manager | Strong Market Fit, Attendance Not Confirmed |
| Amgen | Biotechnology company | Relevant for cardiovascular biology, biologics, and scientific partnerships. | amgen.com | Scientific Director, Business Development Lead, Clinical Program Director | Strong Market Fit, Attendance Not Confirmed |
| Pfizer | Pharmaceutical company | Potential audience for cardiovascular science, external innovation, and clinical development. | pfizer.com | Scientific Leader, Alliance Director, R&D Portfolio Manager | Strong Market Fit, Attendance Not Confirmed |
| Bristol Myers Squibb | Pharmaceutical company | Potential interest in cardiovascular research partnerships and early science. | bms.com | Medical Director, External Research Lead, Program Manager | Strong Market Fit, Attendance Not Confirmed |
| Labcorp | Diagnostics / life sciences services | Clinical research support and biomarker testing relevance. | labcorp.com | Business Development Director, Scientific Partnerships Lead | Strong Market Fit, Attendance Not Confirmed |
| Thermo Fisher Scientific | Life sciences tools / services | Likely exhibitor or commercial prospect for research tools and services. | thermofisher.com | Field Application Scientist, Sales Director, Product Manager | Strong Market Fit, Attendance Not Confirmed |
| Priority | Job Title / Function | Department | Seniority Level | Why This Role Matters |
|---|---|---|---|---|
| 1 | Principal Investigator / Faculty Scientist | Research | Senior | Primary scientific decision-maker for lab equipment, research services, and partnerships. |
| 2 | Director of Research / Research Program Director | Research Administration | Senior | Evaluates program priorities, vendor relationships, and funding alignment. |
| 3 | Lab Manager / Core Facility Director | Operations / Research Support | Mid to Senior | Often controls product evaluation, purchasing, service contracts, and workflow adoption. |
| 4 | Clinical Trial Manager / Translational Program Manager | Clinical Operations | Mid to Senior | Relevant for trial services, analytics platforms, and patient recruitment support. |
| 5 | Medical Director / Translational Medicine Lead | Clinical Development | Senior | High-value contact for biotech/pharma science and collaboration opportunities. |
| 6 | Procurement Manager / Strategic Sourcing Manager | Procurement | Mid to Senior | Manages vendor onboarding, pricing, and sourcing for scientific and clinical suppliers. |
| 7 | Business Development Director / Alliance Manager | Partnerships | Senior | Targets collaboration, licensing, and commercial relationship-building. |
| 8 | Scientific Affairs / Medical Affairs Director | Medical Affairs | Senior | Important for clinical messaging, KOL engagement, and evidence-generation strategy. |
| Priority | Apollo Industry | Why It Fits the Event | Best Buyer Use Case |
|---|---|---|---|
| 1 | Hospital & Health Care | Hospitals and academic medical centers are core attendee organizations. | Cardiology, research, procurement, and lab operations buyers |
| 2 | Research | Scientific discovery meeting with strong research audience. | Principal investigators, research directors, grant-funded labs |
| 3 | Biotechnology | Biotech sponsors and attendees often seek translational research collaborations. | BD, translational science, platform evaluation |
| 4 | Pharmaceuticals | Pharma has direct strategic interest in cardiovascular science. | R&D, medical affairs, external innovation |
| 5 | Medical Devices | Cardiovascular innovation often overlaps with device development and evaluation. | Clinical evidence, product development, KOL engagement |
| 6 | Medical Practice | Cardiologists and physician-scientists are central attendees. | Physician leads, clinical advisors, specialty groups |
| 7 | Medical Devices | Useful for cardiovascular tools, diagnostics, and monitoring technologies. | Product managers, clinical affairs, commercialization |
| 8 | Information Technology & Services | Digital research platforms, data management, and analytics are relevant. | Data platforms, AI tools, workflow software |
| 9 | Higher Education | Universities are core attendance and content contributors. | Faculty, research administration, lab managers |
| 10 | Biotechnology | Strong fit for upstream discovery and translational science vendors. | Scientific partnerships, assay development, CROs |
| Metric | Figure | Status | Source / Basis | Notes |
|---|---|---|---|---|
| Estimated total footfall | Not publicly confirmed | Unconfirmed | Official website excerpt supplied by user does not include attendance count | Use organizer registration data or prior-year press materials if available. |
| Exhibitor count | Not publicly confirmed | Unconfirmed | No exhibitor directory was provided in the source excerpt | Scientific meetings may have limited exhibit footprints compared with major trade shows. |
| Buyer / attendee count | Not publicly confirmed | Unconfirmed | No attendee list or buyer count supplied | Best treated as a high-value scientific audience rather than a volume-driven trade show. |
| Speaker count | Not publicly confirmed | Unconfirmed | No agenda roster provided in the excerpt | Speaker list should be checked on the official program page. |
| Historical attendance | Prior-year official data not provided | Unavailable in supplied source set | Official 2025 page excerpt confirms a prior edition in Baltimore | Prior-year participation evidence. Not a confirmed attendee list for the current edition. |
| Focus Area | Typical Buyer Need | Buyer Engagement Opportunity | Relevant Supplier Offering |
|---|---|---|---|
| Basic cardiovascular research | Tools, assays, models, and reproducible workflows | Sponsor science sessions, workshops, or product demos | Lab instruments, reagents, consumables, imaging systems |
| Translational medicine | Bridging preclinical findings to clinical studies | Target program leads and translational directors | CRO services, biomarker platforms, clinical research support |
| Cardiovascular drug discovery | Early-stage science, target validation, and collaboration | Meet pharma and biotech R&D stakeholders | Screening platforms, data analytics, preclinical services |
| Scientific publishing / education | Knowledge dissemination and CME/CE support | Engage society staff and academic educators | Publishing, learning platforms, event and webinar services |
| Research infrastructure | Shared facilities, data management, and procurement efficiency | Target lab managers and procurement leaders | LIMS, equipment service, managed procurement, financing |
| Factor | Assessment | Explanation |
|---|---|---|
| Buyer relevance | Very High | The audience includes researchers, clinical leaders, and life sciences decision-makers with real commercial and scientific influence. |
| Decision-maker availability | High | Faculty, directors, and industry leads are likely present, although current-year speaker/attendee lists were not supplied. |
| Data collection potential | Medium | High-value audience, but current-year official roster data is not confirmed in the supplied source excerpt. |
| Apollo targeting potential | Very High | Strong fit across Hospital & Health Care, Biotechnology, Pharmaceuticals, Research, and Higher Education. |
| Geographic targeting potential | High | Boston and Northeast life sciences hub provide strong regional account targeting opportunities. |
| Best outreach approach | Technical, research-led, and partnership-oriented | Focus messaging on scientific outcomes, workflow efficiency, and translational value rather than broad consumer-style promotion. |
| Overall lead quality | High | Strong B2B scientific audience with meaningful buyer and influencer presence. |
| Best use case | Lead generation, scientific account targeting, attendee prospecting, and sponsor outreach | Well suited for attendee list sales, lab/clinical supplier targeting, and KOL mapping. |
| Limitations / risks | No confirmed current-year attendee list in supplied source | Prospecting should distinguish between confirmed event participation and broader market-fit targeting. |
| Filter Type | Recommended Filters | Purpose |
|---|---|---|
| Apollo industries | Hospital & Health Care; Biotechnology; Pharmaceuticals; Medical Devices; Research; Higher Education; Information Technology & Services; Medical Practice; Government Administration | Capture scientific, clinical, and commercial buyers relevant to cardiovascular research and translation. |
| Departments | Research; Clinical Development; Medical Affairs; Procurement; Operations; Partnerships; Product; Innovation | Reach both scientific decision-makers and commercial evaluators. |
| Seniority | Manager, Director, VP, CXO, Owner, Partner, Professor | Prioritize budget owners, scientific leaders, and partnership decision-makers. |
| Job titles | Principal Investigator, Professor, Research Director, Lab Manager, Cardiology Director, Clinical Trial Manager, Scientific Director, Medical Director, Procurement Manager, Strategic Sourcing Manager | Targets the most likely buyers and influencers at the meeting. |
| Geography | United States; Northeast; Massachusetts; Boston; Cambridge; New York; Pennsylvania; New Jersey; Connecticut; international research hubs | Prioritize host-market and adjacent life sciences corridors. |
| Employee size | 51–200; 201–500; 501–1,000; 1,001–5,000; 5,000+ | Covers academic groups, biotech firms, and large health systems. |
| Keywords | cardiovascular, cardiology, translational research, preclinical, biomarker, lab, core facility, clinical trial, medical affairs, research | Refines prospects to relevant scientific and operational stakeholders. |
| Company type | Private; Public; Academic; Nonprofit; Government | Includes the full ecosystem of relevant buyers and influencers. |
| Source | Type | What It Verified | Reliability |
|---|---|---|---|
| American Heart Association – BCVS official page | Official organizer website | Event brand, scientific focus, and prior-year page context indicating a 2025 Baltimore edition | High |
| User-provided event details | Provided brief | 2026 date, Boston location, Sheraton Boston venue | Medium; not independently confirmed in the supplied official excerpt |
| AHA site navigation / meetings category structure | Official site content | Confirms BCVS is part of AHA’s scientific meetings ecosystem | High |
| Supplied website excerpt | Primary source excerpt | Described BCVS as a bench science conference and referenced July 23–26, 2025 in Baltimore, MD | High for the prior-year reference |
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to BCVS - Basic Cardiovascular Sciences - American Heart Association — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.